About the Authors

Marc Swidergall

Affiliation Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, United States of America

Scott G. Filler

sfiller@ucla.edu

Affiliations Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, United States of America, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America

Competing Interests

SGF is a co-founder of and shareholder in NovaDigm Therapeutics, Inc.